Introduction
Myc is a central regulator of cell proliferation and apoptosis that is frequently activated in human malignancy (reviewed in Henriksson and LuÈ scher, 1996; Prendergast, 1997; Facchini and Penn, 1998) . In normal cells induced to divide, the levels of Myc increase and remain elevated, indicating it is required throughout the cell cycle for proliferation. Deregulated Myc expression is sucient to drive quiescent cells into S phase to prevent cell cycle exit. Conversely, suppression of Myc blocks mitogenic signals and facilitates terminal dierentiation. Myc can also induce apoptosis, a feature manifested in normal cells when its expression is enforced and uncoupled from the orchestration of other cell cycle regulatory events. Myc is thought to act in the guise of a transcription factor, but the exact mechanisms underlying its oncogenic and apoptotic properties remain obscure.
We previously identi®ed a cellular polypeptide, Bin1, which interacts with the putative transcriptional activation domain of Myc . The interaction depends upon the integrity of the socalled Myc boxes, two evolutionarily conserved segments which are necessary for both cell transformation and apoptosis. Although its adaptor functions appear to be complex, several observations support the hypothesis that Bin1 is a tumor suppressor that controls cell cycle transit and proliferation. First, Bin1 inhibits cell transformation by Myc or adenovirus E1A . Second, Bin1 is related to RVS167, a negative regulator of the cell cycle in yeast (Bauer et al., 1993) . Third, although widely expressed in normal cells, Bin1 is poorly expressed or undetectable in *50% of carcinoma cell lines and primary breast carcinomas examined . Fourth, de®cits in expression are functionally signi®cant, because Bin1 can inhibit the growth of tumor cells which lack endogenous expression . Fifth, similar to several other important tumor suppressors, Bin1 promotes dierentiation in the myogenic pathway and its inhibition suppresses dierentiation (Wechsler-Reya et al., 1998) . Finally, the human Bin1 gene has been mapped to chromosome 2q14 (Negorev et al., 1996) , within a mid-2q region that is deleted in *42% of metastatic prostate cancers (Cher et al., 1996) , and recent investigations suggest that loss of Bin1 function may contribute to prostate tumor progression (unpublished observations). Evidence from genetic, in vitro biochemical association, and co-localization experiments supports interaction between Bin1 and Myc Wechsler-Reya et al., 1997a) but in vivo physical association and functional interaction had not been documented. In addition, Bin1 was shown to inhibit growth by adenovirus E1A as well as Myc, but whether this re¯ected similar or dierent functions was undetermined. In this study, we show that Bin1 physically associates with Myc in cells and inhibits its transcriptional properties and that Bin1 can inhibit malignant cell growth through Mycindependent as well as Myc-dependent mechanisms.
These ®ndings support a role for Bin1 in governing the oncogenic properties of Myc but indicate that Bin1 also has additional roles in cell growth regulation.
Results

Physical and functional association of Myc and Bin1 in cells
Coimmunoprecipitation and transcription activation experiments were performed to examine the ability of Myc and Bin1 to functionally associate in cells. Association of Myc and Bin1 was observed to coimmunoprecipitation from baculovirus-infected Sf9 cells and untransfected C2C12 myoblasts, where Bin1 function has been examined (Wechsler-Reya et al., 1998) , using NP40 buer conditions previously shown to support interaction of Myc and Bin1 in vitro (150 mM NaCl and 0.1% NP40). Bin1 was extracted more readily than Myc by NP40 lysis buer from Sf9 cells infected with recombinant c-Myc and Bin1 baculoviruses, consistent with the fact that ecient extraction of Myc requires harsher conditions (RIPA buer and sonication (Hann et al., 1983) . However, the Myc complexes extracted under these conditions contained Bin1 as indicated by coimmunoprecipitation with Myc antibody (Figure 1a) . Association was speci®c because co-expression of the negative control proteins RhoB or yeast ADA3 with Bin1 did not result in Bin1 precipitation (data not shown). Bin1 antibodies capable to recognizing native Bin1 protein bind to epitopes in the Myc binding domain (MBD) (WechslerReya et al., 1997a) so the reverse immunoprecipitation experiment was intractable. Experiments using epitopetagged Bin1 species were inconclusive, because tags at either the C-or N-terminus of Bin1 were not recognized unless denaturing conditions were used (i.e. RIPA buer) that did not preserve Myc interaction in vitro ; data not shown). However, Myc-Bin1 association was similarly observed in C2C12 cells. Myc and Bin1 are each expressed in proliferating C2C12 cells with Bin1 in stochiometric excess (Wechsler-Reya et al., 1998) . When C2C12 is induced to dierentiate (Blau et al., 1985) , Bin1 is upregulated while Myc is downregulated to undetectable levels (Wechsler-Reya et al., 1998) , providing a useful negative control for association. As before, Myc was extracted ineciently by NP40 buer but Bin1 was detected in Myc complexes that were immunoprecipitated by Myc antibody (Figure 1b) . The presence of Bin1 in these complexes was not due to antibody artifact or another nonspeci®c cause, because Bin1 was not detected in similar immunoprecipitates prepared from dierentiated cell extracts.
To determine whether Bin1 association aected the transcriptional properties of Myc, transient activation assays were performed using a variety of promoters documented to be physiologically activated by c-Myc. The experiments employed luciferase (luc) reporter genes driven by arti®cial Myc-responsive promoters containing either multimerized DNA binding sites upstream of a minimal viral promoter or by the 5' regions of the Myc target genes ornithine decarboxylase (ODC) and a-prothymosin (pT) (Bello-Fernandez et al., 1993; Eilers et al., 1991) . The two arti®cial reporter genes were p3XMycE1b-luc (Gupta et al., 1993) and Gal 5 -E1b-luc, which included either three Myc-binding sites or ®ve yeast GAL4 binding sites upstream of the adenovirus E1b minimal promoter. The latter reporter was used where activation was driven by chimeric molecules containing Bin1 or the Myc N-terminal transactivation domain (aa 1 ± 262) fused to the DNA binding domain of the yeast transcription factor GAL4 (Kato et al., 1990) . The ODC and target gene reporters were ODCDluc and PrT-luc (Bello-Fernandez et al., 1993; Desbarats et al., 1996; Packham and Cleveland, 1997) . Cells were transfected with reporter plasmids and vectors for cMyc or GAL4-Myc, Bin1, or the MBD deletion mutant Bin1DMBD . Max was included in pT experiments for optimal activation of this gene as documented (Desbarats et al., 1996) . 6 cells infected with the recombinant baculoviruses indicated were prepared and subjected to IP/Western analysis as described in the text and the Materials and methods. Dots indicate the position of coprecipitating antibodies recognized by anti-mouse or antirabbit secondary antibodies used to develop the blots, by a chemiluminescence technique. (b) Association in naive C2C12 myoblasts. Extracts from growing (d0) or dierentiated (d5) C2C12 cells were prepared and subjected to Western or IP/ Western analyses as described in the text and the Materials and methods. The left panel is a Western blot of an SDS gel loaded with 50 mg extract from d0 or d5 cells, demonstrating constitutive Bin1 expression and the appearance of a larger alternately spliced species in dierentiated cells (Wechsler-Reya et al., 1998) .The dot indicates a nonspeci®c band. The middle panel is a Western blot of nonreducing SDS gel loaded with a Myc immunoprecipitate (sc-42) generated from 1.5 mg of d0 or d5 extracts and probed with a second anti-Myc antibody (9E10). The right panel is a Western blot of a nonreducing SDS gel loaded with 50 mg of d0 extract alone or a Myc immunoprecipitate (sc-42) from 1.5 mg d0 or d5 extracts and probed with anti-Bin1 99D related protein p107 (Beijersbergen et al., 1994; Gu et al., 1994) .
Bin1 selectively inhibited Myc activation on all the Myc reporter promoters tested (Figure 2) . In NIH3T3 cells, Myc activated p3XMycE1b-luc *2.5-fold, similar to the level observed by others (Kretzner et al., 1992) , and titration of Bin1 into the assay reversed the eect of Myc (Figure 2a) . Similarly, Myc activated the ODC promoter *2.3-fold, also as documented previously (Packham and Cleveland, 1997) , and Bin1 reversed this eect as potently as p107 (Figure 2b) . Deletion of the Myc-binding domain (MBD) from Bin1 relieved its ability to inhibit ODC in both HeLa and NIH3T3 cells (Figure 2c ). The inability of Bin1DMBD to suppress Myc was not due to polypeptide instability nor to general loss of function, because Bin1DMBD accumulated similarly to wild-type Bin1 in transfected COS cells and because Bin1DMBD could inhibit E1A transformation (see below). A more robust activation of pT by Myc-Max was also inhibited by Bin1 *3-fold (Figure 2d ). Bin1DMBD also inhibited Myc activation of pT indicating the eect on this gene was MBDindependent. However, inhibition was speci®c because Bin1 did not aect activation by VP16. Western analysis con®rmed Myc and Max accumulation in transiently transfected cells, ruling out the trivial possibility that Bin1 acted by inhibiting the exogenous Myc or Max expression (data not shown). The speci®city of the eect of Bin1 for the Myc Nterminus was investigated using GAL4-Myc or a second GAL4 chimera which included instead the activation domain from the nonspeci®c but broadly active herpes virus activator VP16 (GAL4-VP16). For these experiments, we examined activation of a pT reporter (GAL4mE-prT-luc) that was identical to the prT-luc reporter used above except that the two Myc were transfected with the plasmids indicated by standard calcium phosphate method and processed for normalized luciferase activity as described (Zhang and Prochownik, 1997) . The data represent the results of three trials each performed in duplicate. (b) Inhibition of ODC activation. NIH3T3 cells seeded into six well dishes were transfected with 1.5 mg of the ODC reporter ODCDluc, 3 mg of the human c-Myc vector LTR Hm, 1.5 mg CMV Bin1 or CMV p107, and 0.5 mg CMV-bgal (to normalize for transfection eciency). pcDNA3 was added to equalize the amount of plasmid in each transfection. Two days later cell extracts were prepared and processed for normalized reporter activity. The graph depicts relative luciferase activity based on reporter only (set at 100%); the absolute values ranged from 10 3 ± 10 4 light units. The results represent the average of two trials each performed in duplicate. (c) MBD is required for ODC inhibition. NIH3T3 or HeLa cells were transfected with 0.5 mg ODCDluc and 2 mg LTR-Hm plus 3.25 mg vector, CMV-Bin1, or CMV-Bin1DMBD. Cell extracts were prepared and processed as above. The results represent the average of two trials performed in duplicate. Relative luciferase activity is depicted as the proportion of reporter plus LTR Hm; the absolute values ranged from 10 3 ± 10 4 light units. (d) Inhibition of pT activation. HeLa cells were transfected with PrT-luc, a bgalactosidase normalization plasmid, and the vectors indicated as described (Desbarats et al., 1996) . Where indicated Bin1 or control plasmids were included in a 1 : 1 w/w ratio with Myc. Relative luciferase activity is depicted as above; the absolute values ranged from 10 4 ± 10 6 light units. (e) Bin1 inhibits GAL4-Myc but not GAL-VP16. HeLa cells were transfected with GAL4mE-PrTluc and the genes indicated as above and processed for relative luciferase activity
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K Elliott et al binding sites in the gene were replaced with GAL4 binding sites (Desbarats et al., 1996) . Bin1 inhibited activation of pT by GAL-Myc but not by GAL4-VP16 ( Figure 2e ). Similar results were obtained with GAL4-E1b-luc (data not shown). Taken together, the results of the immunoprecipitation and transcription experiments argued that Bin1 physically and functionally interacted with Myc in cells.
Bin1 can recruit a transcriptional repression function to DNA
Bin1 does not harbor motifs characteristic of transcription adaptor proteins, so one interpretation of the above results was that Bin1 acted via a passive mechanism, for example, by occluding contacts with as yet unidenti®ed coactivators or with the TATA-binding protein (TBP), which has been reported to interact with Myc (Hateboer et al., 1993) . Alternately, Bin1 may act through an active repressive mechanism, perhaps by recruiting a corepressor to the promoter similar to the Mad-binding protein mSin3 (Ayer et al., 1995; Schreiber-Agus et al., 1995) . To assess the latter hypothesis, we tested the eects of Bin1 on basal transcription of a promoter to which it was tethered in a Myc-independent manner. This was achieved by fusing Bin1 in frame to the DNA binding domain of GAL4 to generate GAL4-Bin1. A second GAL4 chimera that lacked the MBD was constructed (GAL4-Bin1DMBD) to eliminate MBDdependent interactions with Myc, Myc-binding coactivators yet to be identi®ed, or possibly TBP (Hateboer et al., 1993) , all of which might mask repressive eects or make their interpretation more dicult. HeLa cells were transfected with the arti®cial promoter-reporter gene GAL 5 -E1b-luc and equivalent amounts of expression vectors for unfused GAL4 DNA binding domain (GAL0), GAL4-Bin1, or GAL4-Bin1DMBD and cell lysates were processed for luciferase activity as before. GAL4-Bin1 was only slightly inhibitory but GAL4-Bin1DMBD repressed basal transcription *2.5-fold relative to unfused GAL0 (Figure 3a ). GAL4-Bin1DMBD had little eect on the activity of luciferase reporters lacking GAL4 sites (data not shown), indicating that this eect was dependent on DNA binding. To determine if repression re¯ected recruitment of a Bin1-binding factor, we added vector, wild-type (untethered) Bin1, or Bin1DMBD to the cotransfection. If the activity was intrinsic, cotransfection of Bin1 would not aect repression, whereas if repression was due to recruitment of a trans-acting factor then untethered Bin1 would be predicted to titer the repressive eect. Consistent with the latter case, both Bin1 and Bin1DMBD relieved repression by GAL4-Bin1DMBD (Figure 3b ). The greater relief provided in Bin1DBD suggested that a region outside of the MBD might recruit a repression function. Experiments in which trichostatin A was added did not relieve the repressive eect of GAL4-Bin1DMBD suggested that a region outside of the MBD might recruit a repression function. Experiments in which trichostatin A was added did not relieve the repressive eect of GAL4-Bin1DMBD (data not shown), suggesting that this function was not a histone deacetylase and that Bin1 acts dierently than mSin3 (Facchini and Penn, 1998) . Nevertheless, the results suggested that Bin1 may actively inhibit Myc activation by recruiting a repression function.
Expression and localization of Bin1 deletion mutants
To identify non-MBD regions that are important for Bin1 activity a set of deletion mutants was constructed a b S-methionine/cysteine, and cell extracts were prepared and subjected to immunoprecipitation with Bin1 monoclonal antibodies. Immunoprecipitates were examined by SDS ± PAGE and uorography. The bars at the bottom of the cartoon denote regions that are structurally related among proteins of the BAR family, which includes Bin1, amphiphysin, and RVS167 . (b) Localization of Bin1 mutants. 293T cells seeded on glass cover slips were transiently transfected with the expression vectors and processed for indirect immuno¯uorescence with Bin1 monoclonal antibody 99D as described in the Materials and methods amphiphysin/RVS167 homology in this region; BAR-C represents the C-terminal half of the BAR domain (Figure 4a ). The SH3 domain located at the Cterminus is dispensable for interaction with Myc . The central region is not conserved in amphiphysin or RVS167 and is unique to Bin1. This region includes the so-called unique-1 (U1) region encoded in the human gene by exon 9; the alternately spliced and strongly positively charged unique-3 (U3) region encoded by exon 10; the unique-2 (U2) region encoded by exon 11 which harbors two copies of the SH3 binding motif PXXP; and the MBD (Wechsler-Reya et al., 1997b) . The MBD as initially de®ned encompassed aa 270 ± 389. Deletions of three subsections of this segment were generated for this study, aa 270 ± 288, aa 270 ± 315 (comprising the newly de®ned U2 region) and aa 323 ± 356 (N-terminal half of the MBD). Expression of the mutant polypeptides was con®rmed by immunoprecipitation from COS cell extracts. Cells were transfected with vectors for each mutant, metabolically labeled with 35S-methionine, and extracts were prepared and processed for immunoprecipitation with a mixture of Bin1 monoclonal antibodies (Wechsler-Reya et al., 1997a) . The apparent and predicted MWs of the mutants did not coincide in each case because of the presence of a determinant for aberrant gel mobility that maps to the MBD region . Each mutant was observed to accumulate as eciently as full-length Bin1 (Figure 4a ). The cell localization of several mutants was examined by indirect immunouorescence in transiently transfected 293T cells (Figure 4b) . The presence of an SV40 replication origin on the expression vectors made it possible to distinguish cells expressing exogenous proteins by using a higher dilution of Bin1 monoclonal antibody than needed to detect endogenous expression (1 : 100 instead of 1 : 5 dilution). Consistent with previous results Wechsler-Reya et al., 1997a) , wild-type Bin1 localized exclusively to the nucleus, as did Bin1 mutants lacking the U1, U2, U3 and SH3 regions (Bin1DU1 was also preferentially excluded from the nucleolus). U3 contains a nuclear localization motif but its dispensability for nuclear localization was consistent with recent ®ndings in which alternate splicing of the exon encoding U3 after myoblast dierentiation is correlated with the appearance of cytosolic Bin1 species (Wechsler-Reya et al., 1998; Wechsler-Reya et al., 1997b) . Instead, BAR-C contained a critical nuclear localization signal, because both nuclear and cytosolic staining was detected in cells transfected with Bin1DBAR-C. We concluded that BAR-C sequences between aa 125 ± 207 included signal(s) for nuclear localization and/or retention.
Bin1 inhibits malignant cell transformation by multiple mechanisms
Using the Ras cooperation assay performed in primary rat embryo ®broblasts (REFs) (Land et al., 1983; Ruley, 1983) , we previously showed that Bin1 inhibits malignant transformation by c-Myc in a MBDdependent manner . To de®ne other regions required, REFs were transfected with expression vectors for Myc, oncogenic Ras, and Bin1 or Bin1 deletion mutants, and transformed cell foci were scored 2 weeks later ( Figure 5 ). Consistent with previous results , wild-type Bin1 suppressed focus formation by Myc *sixfold relative to the empty vector control. Most deletion mutants inhibited focus formation as eciently as wild-type Bin1, suggesting modularity in the structural organization of this polypeptide. Only BAR-C or the MBD segment aa 323 ± 356 were required, identifying BAR-C determinants as crucial to inhibit Myc transformation along with the MBD. Since aa 270 ± 315 (U2 region) was dispensable for inhibiting Myc transformation the critical part of the MBD therefore was con®ned to a 66 residue segment between aa 323 ± 389. The inactivity of the MBD aa 323 ± 356 or BAR-C deletion mutants was not due to protein instability, because each polypeptide accumulated similar to wt Bin1 in COS cells (Figure  4a ), nor to misfolding, because each polypeptide eciently suppressed transformation by E1A or mutant p53. Bin1DBAR-C localized to the nucleus and cytoplasm (Figure 4b ) but its ability to suppress E1A and mutant p53, which act in the nucleus, also argued against mislocalization as the cause for loss of activity against Myc. We previously showed that Bin1 inhibited transformation by adenovirus E1A but not SV40 large T antigen , and in this study we show that Bin1 also inhibited transformation by dominant inhibitory mutant p53. Bin1 suppressed transformation by E1A or mutant p53 *threefold ( Figure 6) ; the inhibitory eects of each could be titered as was the case with Myc by altering the ratio of Bin1 to E1A or mutant p53 in the assay (data not shown). U1 was crucial to inhibit E1A and U1 and SH3 were both crucial to inhibit mutant p53 (Figure 6 ). U3, BAR-C, and MBD were each dispensable to inhibit either oncoprotein. As before, neither protein instability nor misfolding was responsible for the loss of activity of either mutant since each accumulated in COS and each could suppress Myc transformation (Figures 4a and 5 ). Northern analyses of RNA isolated from pools of foci derived from Myc+Ras, E1A+Ras, or mutant p53+Ras transfections showed that, as predicted, mutant Bin1 messages accumulated in transformed cells if the mutant was biologically inactive. For example, Bin1DBAR-C message only accumulated in Myc+Ras foci whereas Bin1DU1 message only accumulated in E1A+Ras or mutant p53+Ras foci (data not shown). Thus, the domains required to inhibit E1A and mutant p53 were distinct from those required to block Myc. The importance of the BAR-C domain to the inhibitory activity of Bin1 was con®rmed in HepG2 cells (Figure 7) . Deletion of other domains only partly relieved HepG2 growth consistent with the likelihood that multiple growth mechanisms were deregulated in these tumor cells (data not shown). Notably, MBD deletion also only slightly relieved suppression, underscoring the importance of MBD-independent mechanisms for some types of growth inhibition by Bin1. Since neither E1A nor mutant p53 require endogenous Myc to transform cells, the dierences in domain dependence argued that Bin1 could regulate malignant cell proliferation through Myc-independent as well as Myc-dependent mechanisms.
Discussion
This study supports the assertion that Myc and Bin1 physically and functionally associate in cells, and it showed that Bin1 can inhibit malignant cell proliferation by both Myc-dependent and Myc-independent mechanisms (Figure 8 ). Myc-Bin1 complexes were detected by coimmunoprecipitation from recombinant baculovirus-infected Sf9 cells or from naive C2C12 cells. The fact that Myc-Bin1 complexes could be identi®ed in growing C2C12 cells suggested that association is not inhibitory per se but may be subjected to posttranslational regulation. This possibility would be consistent with demonstrations that Bin1 is phosphorylated and associated in vivo with other proteins in addition to Myc (Wechsler-Reya et al., 1997a) . The ability of Bin1 to speci®cally inhibit Myc function as measured by activation of arti®cial and natural target genes supported in vivo association. Activation by Myc/Max or by GAL4-Myc chimeras containing the Myc transactivation domain, but not by GAL4-VP16, was susceptible to Bin1 inhibition. VP16 is a complex activator that can act through a variety of adaptors, so the fact that VP16 was not inhibited by Bin1 indicated that its activity was speci®c and not due to nonselective suppression of transcriptional activation. ODC and pT are two paradigm target genes for Myc and the ability of Bin1 to inhibit each supported the notion of functional interaction. Whether Bin1 has 
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K Elliott et al a physiological role in transcription bears further analysis. However, in support of this possibility we showed that Bin1 could recruit a potential repression function to DNA via an MBD-independent interaction. In addition, Myc has been reported to interact in vitro with TATA-binding protein (Hateboer et al., 1993) and we have observed that the Bin1 MBD can avidly bind TBP in vitro (D Sakamuro and GC Prendergast, unpublished observations). Although the consequences of Myc-TBP interaction have not been established in vivo the ability of Bin1 to bind TBP conceivably represents a second mechanism through which Bin1 could disrupt Myc activation. As considered above, it is possible that the inhibitory eects of Bin1 on Myc activation are passive and an epiphenomenon of steric occulusion of coactivators which are yet to be identi®ed. Recent results indicated that Bin1 is necessary for Myc-mediated apoptosis (D Sakamuro, J Duhadaway and GC Prendergast, unpublished observations) would provide a biological foundation to assess the physiological signi®cance of the putative transcriptional properties of Bin1 documented in this study.
The N-terminal BAR-C region of Bin1 was required to inhibit Myc transformation. BAR-C is a charged region of 84 aa predicted to be both a helical and involved in coiled-coil interactions (Lupas, 1996) . A key functional role for this region is supported by the fact that it contains the most highly conserved sequences in Bin1 in evolution. Given the requirement for MBD and BAR-C to suppress Myc transformation one might have expected both regions to be important for the inhibitory eects of Bin1 in HepG2, which overexpresses Myc. However, if Myc-independent growth pathways deregulated in HepG2 are dominant or co-dominant with Myc-dependent pathways then this would not be expected to be the case. BAR-C included a signal(s) for nuclear localization or retention, while NLS-like sequences in U3 have been shown here and elsewhere (Wechsler-Reya et al., 1998) to be dispensable. The results of this study mapped the MBD within a 61 residue segment between aa 315 ± 376 immediately upstream of the SH3 domain. Interestingly, this region of Bin1 is encoded by two exons and the more 5' exon has been found to be alternately spliced in cells (Wechsler-Reya et al., 1997b) . The aa 323 ± 356 deletion which relieved Myc suppression activity closely overlaps the sequences encoded by this exon. Thus, one alternately spliced Bin1 species in cells probably lacks Myc binding capacity and functions independently of Myc, a likelihood that is consistent with Myc-independent growth inhibitory properties of Bin1 identi®ed in this study. Alternative splice forms of Bin1 that are neuron-speci®c, termed amphiphysin-like isoform or amphiphysin II, have been implicated in endocytosis (Wigge and McMahon, 1998) . However, we do not believe endocytosis is relevant to the Mycindependent growth inhibition mechanisms identi®ed here, because non-neuronal splice forms lack determinants required for interaction with endocytosis systems (Ramjaun and McPherson, 1998) and because the inclusion of neuron-speci®c exons in Bin1 eliminates its growth inhibitory activity (unpublished observations).
The C-terminal U1 and SH3 regions were required to inhibit transformation by E1A or p53 but not by Myc. U1 is contained on a single exon which encodes 28 aa (Wechsler-Reya et al., 1997b) . E1A transforms cells by displacing E2F from Rb (Dyson and Harlow, 1992) so U1 either impedes this process somehow or acts downstream to interfere with E2F eectors. Consistent with a link between U1 and the Rb/E2F system, U1 deletion also blocks transformation by the human papilloma virus E7 protein (data not shown), which acts similarly to E1A by interfering with Rb/ E2F interaction (Phelps et al., 1988) . The requirement of U1 to inhibit mutant p53 is consistent with evidence that cell transformation by mutant p53 also depends on interference with Rb/E2F interactions (Hansen et al., 1995) . The SH3 domain of Bin1 was also necessary to inhibit transformation by mutant p53. To our knowledge Bin1 and Abl are the only two SH3-containing proteins localized to the nucleus, and recently Abl has been shown to interact with Bin1 in an SH3-dependent manner (Kadlec and Pendergast, 1997; D Sakamuro and GC Prendergast, unpublished observations) . This may be of consequence since Abl and p53 have been reported to interact in cells (Yuan et al., 1996) , although the physiological signi®cance of this interaction has not been established clearly. Direct interaction between the Bin1 SH3 and the PxxP motifs in the apoptosis eector domain of p53 (Sakamuro et al., 1997) could be germane since PxxP motifs constitute SH3 ligands. Indeed, since this region also has been implicated in growth inhibition (Walker and Levine, 1996) and the transforming eciency of mutant p53 rests upon more than simple inactivation of endogenous p53 (Dittmer et al., 1993; Hulboy and Lozano, 1994) , it is conceivable that mutant p53 may promote transformation in a PxxP-dependent manner by sequestering a nuclear SH3-containing growth suppressor such as Bin1.
Materials and methods
Plasmid constructions
The following plasmids have been described. CMV-Bin1 and CMV-Bin1DMBD encode full-length Bin1 or an MBD deletion mutant, respectively . LTR Hm contains a Moloney retroviral long terminal repeatdriven normal human c-myc gene (Kelekar and Cole, 1986) ; pSVLneo-C-myc is an SV40 early region-driven c-Myc vector used in Figure 2a that has been described (Zhang and Prochownik, 1997) ; p1A/neo contains the 5' end of the adenovirus type 5 genome including the E1A region (Maruyama et al., 1987) ; LTR p53ts encodes a temperature-sensitive dominant inhibitory mutant of murine p53 (Michalovitz et al., 1990) ; and pT22 contains an activated Hras gene (Land et al., 1983) . CMV-p107 contains a full-length human p107 cDNA (Zhu et al., 1993) in the cytomegalovirus enhancer/promoter-containing vector pcDNA3 (Invitrogen). P3XMyc-Elb-luc is an arti®cial reporter gene containing multimerized CACGTG Myc E box sequences upstream of the minimal adenovirus E1b promoter (Gupta et al., 1993) . GAL4-E1b-luc and GAL4-SV40-luc are GAL4 reporters which contain multimerized GAL4 sites upstream of the minimal E1b or SV40 early promoters (gifts of F Rauscher III). The ODC luciferase reporter ODCDluc and the aprothymosin luciferase reporters PrT-luc and GAL4mE-PrTluc have been described (Desbarats et al., 1996; Packham and Cleveland, 1997) . The BacBin baculovirus was prepared by standard methods (O'Reilly et al., 1992) using the baculovirus expression vector pVL1392 (Invitrogen) into which the full-length Bin1 cDNA was subcloned. A murine c-Myc baculovirus (a gift of M Cole) was prepared similarly. GAL0 is the DNA binding domain of GAL4 (aa 1 ± 143) and GAL4-Myc includes aa 1 ± 262 of human Myc except the b/HLH/LZ region (Kato et al., 1990) which is necessary to bind Max . Bin1 deletion mutants and GAL4 fusion genes were subcloned for expression in pcDNA3 (the same vector as Bin1 and Bin1DMBD). Bin1DBAR-C was constructed by dropping an internal AĪ II restriction fragment from CMV-Bin1, resulting in a deletion of aa 125 ± 207 from the BAR domain . The remaining mutants were generated by standard PCR methodology using the oligonucleotide primers 995'(Bam), 993'SH3(Xho) and others whose sequence is derived from the Bin1 cDNA sequence (GenBank accession number U68485). The integrity of PCRgenerated fragments was veri®ed by DNA sequencing. To conserve space, oligonucleotides and construction details are omitted but are available from GC Prendergast. Bin1DU1 lacks aa 224 ± 248; Bin1DNLS, aa 251 ± 269; Bin1DSH3, aa 384 ± 451; the other mutants lack the residues indicated. GAL4-Bin1 fusions were generated in two steps by ®rst subcloning the 143 aa DNA binding domain from GAL0 into pcDNA3 and then ligating in-frame full-length Bin1 or Bin1DMBD (lacking aa 270 ± 383) cDNAs downstream.
Cell culture
COS, 293T, HeLa, and HepG2 cells from the ATCC were maintained in Dulbecco's modi®ed Eagle's media (DMEM) supplemented with 10% fetal bovine serum (Atlantic) and 40 U/ml penicillin and streptomycin (Fisher). NIH3T3 cells were cultured in DMEM supplemented with 10% calf serum (Gibco) and antibiotics (transfections were performed in media containing 10% fetal calf serum). C2C12 cells were carried in DMEM supplemented with 15% fetal bovine serum and antibiotics. Dierentiation of C2C12 was induced by removing shifting cells at *70% con¯uence to DMEM supplemented with 5% horse serum and antibiotics for 5 days, when myotube formation was maximal. Secondary passage rat embryo ®broblasts (REFs) were obtained from Whittaker Bioproducts and cultured and transfected as described (Prendergast et al., 1992) . For transformation assays, secondary passage REFs seeded in 10 cm dishes were transfected overnight by a calcium phosphate coprecipitation method (Chen and Okayama, 1987) with 5 mg each of oncogenic Ras plus Myc, E1A, or mutant p53 expression plasmids and 10 mg of Bin1 plasmid or empty vector. Cells were fed and the next day passaged into one 15 cm dish (Myc transfections) or three 10 cm dishes (ElA or mutant p53 transfections). Foci were scored by methanol ®xation and crystal violet staining 12 ± 16 days later. Colony formation assays in HepG2 cells were performed by seeding *3610 5 cells in 6 cm dishes and transfecting the next day with 2 mg plasmid DNA using Lipofectamine (Gibco/BRL). Cells were passaged 48 h after transfection at a 1 : 10 ratio into 6 cm dishes containing media with *0.6 mg/ml G418 and cell colonies were scored by crystal violet staining *3 weeks later.
Immunoprecipitation
For insect cell experiments, *10 7 Sf9 cells were infected with the recombinant baculoviruses indicated at an m.o.i. of approximately 10. Two days after infection, cells were harvested and *2610 6 cells for each IP were extracted in 0.5 ml 50 mM TrisCl pH 8/150 mM NaCl/0.1% NP40. Clari®ed lysates were subjected to immunoprecipitation by incubation 1.5 h at 48C with 1 mg of anti-murine c-Myc antibody #6 ± 213 (Upstate Biotechnology) or 100 ml hybridoma supernatant containing the Bin1 monoclonal antibody 99D (Wechsler-Reya et al., 1997a) . Immune complexes were collected on Protein G-Sepharose (Pharmacia), washed four times with binding buer, eluted by boiling in SDS gel loading buer, and fractionated by SDS ± PAGE. Gels were Western blotted by standard methods (Harlow and Lane, 1988) and probed with 1 mg/ml anti-Myc or a 1 : 50 dilution of 99D hybridoma supernatant. Blots were developed using a chemiluminescence kit (Pierce). For experiments in mouse cells, 5 ± 10 dishes of growing or dierentiated C2C12 cells were trypsinized, washed with excess growth media and then with 30 ml PBS each at 48C. All subsequent steps were performed on ice or at 48C. Cells were resuspended in hypotonic buer (10 mM HEPES pH 8.0, 10 mM KCl, 0.1 mM EDTA, and 1 mM PMSF, aprotinin, leupeptin, antipain), incubated 3 ± 5 min, and pelleted. These swollen cells were resuspended in extraction buer (20 mM HEPES, pH 8.0, 100 mM KCl, 0.1 mM EDTA, 0.1% NP-40, and protease inhibitors) and lysed by 10 strokes with a B pestle homogenizer. Before immunoprecipitation, the extract was incubated 15 min and clari®ed by a 5 min microcentrifugation. The protein concentration in the extract was determined by Bradford assay and 1.5 mg was incubated overnight with 1 mg anti-c-myc #sc-42 (Santa Cruz Biotechnology). Immune complexes were collected on protein G-agarose, washed three times with extraction buer, and fractionated by nonreducing SDS ± PAGE. Gels were Western blotted and probed as indicated with a 1 : 50 dilution of 99D hybridoma supernatant or *1 mg/ml anti-Myc antibody 9E10 (Evan et al., 1985) . Blots were developed in these experiments with a secondary goat anti-mouse antibody conjugated to alkaline phosphatase, using an colormetric staining reaction catalyzed by this enzyme. To con®rm expression of Bin1 deletion mutants, COS cells were metabolically labeled for 2 h in DMEM lacking methionine and cysteine (Gibco) with 100 mCi/ml EXPRESS labeling reagent (NEN) and cell extracts were prepared with NP40 buer containing leupeptin, aprotinin, phenylmethylsulfonyl¯uoride, and antipain (Harlow and Lane, 1988) . Extracts were microcentrifuged for 15 min at 48C before use. Extracts were precleared by a 1 h treatment with prebleed sera or normal mouse IgG and 20 ml or a 1 : 1 slurry of protein G-Sepharose beads at 48C on a nutator (Pharmacia). A mixture of hybridoma supernatants (50 ml each) containing Bin1 monoclonal antibodies 99D, 99E, and 99I were used for immunoprecipitation (Wechsler-Reya et al., 1997a) . After incubation 1 h at 48C, immune complexes were collected on protein G-Sepharose, washed four times with NP40 buer, eluted in SDS gel loading buer, fractionated on 10% SDS-PA gels, and¯uorographed.
Immuno¯uorescence
293T were seeded onto glass cover slips in six well dishes and transfected the next day with 5 mg of the Bin1 expression vectors indicated. Two days later, cells were ®xed, lysed, and processed for Bin1 immuno¯uorescence as described previously Sakamuro et al., 1996; Wechsler-Reya et al., 1997a) , except that a 1 : 100 instead of a 1 : 5 dilution of 99D was used to limit detection to cells overexpressing the gene products of interest. Cells were photographed on a Leica immuno¯uorescence microscope apparatus using Ektachrome ®lm and slides were scanned and processed with Photoshop software.
Transactivation assays
Conditions for transient Myc activation assays were taken from the reports using the various reporter genes employed (Bello-Fernandez et al., 1993; Desbarats et al., 1996; Kato et al., 1990; Packham and Cleveland, 1997; Zhang and Prochownik, 1997) . NIH3T3 or HeLa cells were transfected using standard calcium phosphate methods and promoter sequences and total plasmid DNA in each transfection was equalized with empty vectors as appropriate. Each DNA mixture included equivalent amounts of a b-galactosidase
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K Elliott et al vector to normalize for transfection eciency. Two days after transfection, cell extracts were prepared and analysed for luciferase and b-galactosidase activity using commercial kits, following protocols provided by the vendor (Promega).
